Bridgefront Capital’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Buy
29,401
+20,133
+217% +$748K 0.3% 97
2026
Q1
$371K Buy
9,268
+1,326
+17% +$62.8K 0.09% 335
2025
Q4
$357K Sell
7,942
-5,708
-42% -$264K 0.09% 340
2025
Q3
$610K Buy
+13,650
New +$653K 0.18% 192
2025
Q2
Sell
-10,677
Closed -$429K 806
2025
Q1
$429K Buy
10,677
+4,536
+74% +$191K 0.12% 296
2024
Q4
$281K Buy
+6,141
New +$275K 0.09% 379
2023
Q4
Sell
-11,662
Closed -$501K 532
2023
Q3
$501K Buy
11,662
+3,902
+50% +$182K 0.35% 75
2023
Q2
$371K Buy
+7,760
New +$374K 0.2% 194

Other funds holding QGEN

Bridgefront Capital's QGEN Position: Q2 2026 in Review

Bridgefront Capital increased its Qiagen (QGEN) stake by 217% in Q2 2026, buying an estimated $748K and bringing the position to 29,401 shares worth $1.15M. The position accounts for 0.3% of the portfolio, ranked #97.

Bridgefront Capital first reported a position in QGEN in Q2 2023 and has held it in 8 quarters since. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Bridgefront Capital held 29,401 shares of Qiagen worth $1.15M as of Q2 2026.
  • Bridgefront Capital bought 20,133 Qiagen shares in Q2 2026, an estimated $748K.
  • Qiagen made up 0.3% of Bridgefront Capital's portfolio in Q2 2026, its #97 holding.
  • Bridgefront Capital first reported a position in Qiagen in Q2 2023 and has held it in 8 quarters since.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.